Mario Sarcletti
Overview
Explore the profile of Mario Sarcletti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borena W, Kitchen M, Gisinger M, Taylor N, Oberkofler H, Dewasurendra D, et al.
Front Public Health
. 2024 Oct;
12:1437309.
PMID: 39371203
Background: In this study, we characterized the HPV genotype distribution in a population of 489 adults already positive for HPV DNA. The study population was divided into two groups: 244...
2.
Kitchen M, Borena W, Gisinger M, Meindl E, Wanner M, Govrins M, et al.
Infection
. 2024 Aug;
PMID: 39093382
Purpose: Asymptomatic pharyngeal gonorrhoea could play an important role in transmission and should be screened for in persons at risk. We investigated the sensitivity of oral gargle samples to detect...
3.
Ambia J, Ingle S, McGinnis K, Pantazis N, Silverberg M, Wittkop L, et al.
Open Forum Infect Dis
. 2024 Jul;
11(7):ofae333.
PMID: 39015347
Background: Predicting cause-specific mortality among people with HIV (PWH) could facilitate targeted care to improve survival. We assessed discrimination of the Veterans Aging Cohort Study (VACS) Index 2.0 in predicting...
4.
Byonanebye D, Polizzotto M, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, et al.
Lancet HIV
. 2024 Apr;
11(5):e321-e332.
PMID: 38621392
Background: Integrase strand-transfer inhibitors (INSTIs) and tenofovir alafenamide have been associated with weight gain in several clinical trials and observational cohorts. However, whether weight gain associated with INSTIs and tenofovir...
5.
Chromy D, Sadoghi B, Gasslitter I, Skocic M, Okoro A, Grabmeier-Pfistershammer K, et al.
J Dtsch Dermatol Ges
. 2024 Feb;
22(3):389-397.
PMID: 38308171
Background And Objectives: Serovar L1-L3 of Chlamydia trachomatis (CT) causes lymphogranuloma venereum (LGV). A surge in LGV-cases has been observed among HIV-positive men who have sex with men (MSM). Discrimination...
6.
Kitchen M, Gasslitter I, Gisinger M, Deeg J, Rieger A, Sarcletti M
Int J STD AIDS
. 2023 Nov;
35(3):234-239.
PMID: 37963428
: The incidence of pyogenic spondylodiscitis has been increasing in countries of Europe and North America, probably due to an increasing number of persons with risk factors for this infection....
7.
Denicolo S, Laydevant S, Fink J, Geiger C, Pizzini A, Sarcletti M, et al.
BMC Infect Dis
. 2022 Oct;
22(1):770.
PMID: 36192705
Background: Sarcoidosis is a systemic inflammatory disease that is characterized by non-caseating epithelioid-cell granulomas upon histology. However, similar histological findings may also be seen with certain infections. Thus, differentiation from...
8.
Kitchen M, Leierer G, Kistner O, Wodal W, Gisinger M, Zangerle R, et al.
Vaccine
. 2022 May;
40(29):3948-3953.
PMID: 35606234
Introduction: Vaccination against seasonal influenza is recommended for all HIV-infected persons. Few data have been reported on the effect of repeated annual vaccination in this population. Methods: We measured haemagglutination...
9.
Kusejko K, Tschumi N, Chaudron S, Nguyen H, Battegay M, Bernasconi E, et al.
J Acquir Immune Defic Syndr
. 2022 Mar;
90(4):e4-e12.
PMID: 35298446
Objectives: Phylogenetic analyses of 2 or more countries allow to detect differences in transmission dynamics of local HIV-1 epidemics beyond differences in demographic characteristics. Methods: A maximum-likelihood phylogenetic tree was...
10.
Byonanebye D, Polizzotto M, Neesgaard B, Sarcletti M, Matulionyte R, Braun D, et al.
HIV Med
. 2022 Mar;
23(8):895-910.
PMID: 35233903
Objective: To compare the incidence of hypertension in people living with HIV receiving integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) versus non-nucleoside reverse transcriptase inhibitors (NNRTIs) or boosted protease...